A former FDA reviewer offers advice to help innovative medtech avoid new and more dangerous pitfalls as experts leave the ...

More and more devices using AI and machine learning technology are becoming available for purchase, something that’s just as ...

AI may provide an answer to the question of whether drugs initially developed and prescribed for non-neurodegenerative physical conditions can be used to treat individuals with Parkinson’s disease.

The FDA announced last week it launched Elsa, an AI tool designed to help employees work better. AI also is impacting ...

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” first quarter 2025 investor ...

AMA survey shows physicians warming up to AI, but there’s still need to ensure such tools are developed and used responsibly ...

The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based ...

JBA AI has been officially recognized by the United States Food and Drug Administration (FDA) as a Software as a Medical ...

Artificial intelligence (AI) already helps clinicians to make diagnoses, triage critical cases and transcribe clinical notes ...

Mark Daly discusses the transformative role of AI in ophthalmology, highlighting its potential to enhance patient care and ...

SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...